Jonathan R Arnow, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Radiology Department, Marlborough, MA 01752 Phone: 508-486-5605 Fax: 508-486-5506 |
Jonathan Michael Glanzman, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 508-486-6700 |
Allison H Sacher, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 508-481-5000 |
Darren D Brennan, M.D. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 508-486-5600 Fax: 508-229-1241 |
Mark W Sykes, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 157 Union St, Radiology Department, Marlborough, MA 01752 Phone: 508-486-5605 Fax: 508-486-5506 |
Dr. Jacqueline L Wellman, M.D. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 157 Union St, Marlborough Hospital, Marlborough, MA 01752 Phone: 774-261-0177 |
Brian T Brochu, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 508-486-5600 |
Olena M Saikewicz, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 118 Barnard Rd, Marlborough, MA 01752 Phone: 978-934-8237 Fax: 978-934-8285 |
News Archive
In a study published in Pediatric Obesity, a child's high and increasing body mass index between ages two and six years was strongly associated with pre-pregnancy obesity and overweight in the child's mother; modestly associated with maternal type 1 diabetes, type 2 diabetes, gestational diabetes that required medication, and excessive weight gain during pregnancy; and slightly associated with breastfeeding for six months or less.
Ajinomoto announced today a new initiative to develop propriety fermentation technology for producing cystine and cysteine, amino acids important in a wide array of applications, including pharmaceuticals, flavorings, and cosmetics.
EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
A custody case in Texas has sparked heated debate and embroiled state policymakers in public discussions about the diagnosis and appropriate medical treatment of transgender children.
The National Institutes of Health is funding bold, new research ideas that focus on interventions to address health disparities and advance health equity.
› Verified 5 days ago